Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120: Negative Results Fail to Trigger a Phase 3 Correlates Trial

BACKGROUND: A goal of T-cell HIV vaccines is to define the correlation between a vaccine-induced immune response and protection from HIV infection. We conducted a phase 2 trial to determine if a canarypox vaccine candidate (vCP1452) administered with rgp120 subunit protein would “qualify” for a tria...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Russell, Nina D., Graham, Barney S., Keefer, Michael C., McElrath, M. Juliana, Self, Steve G., Weinhold, Kent J., Montefiori, David C., Ferrari, Guido, Horton, Helen, Tomaras, Georgia D., Gurunathan, Sanjay, Baglyos, Lynn, Frey, Sharon E., Mulligan, Mark J., Harro, Clayton D., Buchbinder, Susan P., Baden, Lindsey R., Blattner, William A., Koblin, Beryl A., Corey, Lawrence
Format: Artigo
Jezik:Inglês
Izdano: 2007
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2362395/
https://ncbi.nlm.nih.gov/pubmed/17106277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.qai.0000248356.48501.ff
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items